Colorado Springs, CO8 Active Studies

Pulmonary Embolism Clinical Trials in Colorado Springs, CO

Find 8 actively recruiting pulmonary embolism clinical trials in Colorado Springs, CO. Connect with local research sites and explore new treatment options.

8
Active Trials
7
Sponsors
3,120
Enrolling

Recruiting Pulmonary Embolism Studies in Colorado Springs

About Pulmonary Embolism Clinical Trials in Colorado Springs

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 8 pulmonary embolism clinical trials recruiting participants in Colorado Springs, CO. These studies are seeking a combined 3,120 participants. Research is being sponsored by Duke University, Pfizer, Takeda and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Colorado Springs — FAQ

Are there pulmonary embolism clinical trials in Colorado Springs?

Yes, there are 8 pulmonary embolism clinical trials currently recruiting in Colorado Springs, CO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Colorado Springs?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Colorado Springs research site will contact you about next steps.

Are clinical trials in Colorado Springs free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Colorado Springs studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 8 active trials in Colorado Springs are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated July 17, 2026 from ClinicalTrials.gov